Knowledge graph · Cancer
Head and Neck Carcinoma, Other
cancer
- Identifier
- CI-CAN-00009357
- Entity page
- /cancer/head-and-neck-carcinoma-other ↗
- Edges
- 185
- Neighbours
- 8 genes15 drugs10 trials
- Drawn
- 33 of 33 neighbours (cap 60); table lists every fetched edge
Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.
Most connectedLung Non-Small Cell Carcinoma 3,149Malignant Colorectal Neoplasm 1,866ABL1 298EGFR 276Imatinib 450Dasatinib 321
Neighbourhood
Radial view
Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.
Edges
Every edge, grouped by relationship
Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.
| Relationship | Neighbour | Direction | Evidence level | Cancer context | Support | Claim | Source | Expand |
|---|---|---|---|---|---|---|---|---|
| Head and Neck Carcinoma, Other approved for …APPROVED_FORderived6 of 6 | ||||||||
| ← approved for | Selpercatinibsmall molecule FDA (US) · approved · 2024-04-10 · Adult and pediatric patients 2 years of age and older with advanced or metastatic medullary thyroid cancer (MTC) with a RET mutation, as de… | — | approved | Thyroid Gland Medullary Carcinoma | 1 | Regulatory | openfda | graph → |
| ← approved for | ||||||||